Omission of Data and Errors in Meta-Analysis

To the Editor On behalf of my coauthors, I write to report an omission of data from 1 trial reported in our article, “Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis,” that was published online first on March 13, 2017, and in the June 2017 issue ofJAMA Internal Medicine. We are grateful to the reader who pointed out this omission and for the opportunity to correct the article. Our meta-analysis included data from 9 trials comprising 8127 patients that compared major renal outcomes in nondiabetic patients with chronic kidney disease (CKD) who received intensive blood pressure (BP) control (<130/80 mm Hg) vs standard BP control (<140/90 mm Hg). We inadvertently failed to include mortality data from the SPRINT trial in the summary estimate for overall mortality.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research